Skip to main content
SpringerLink
Log in

Patent watch

Drug patenting in India: looking back and looking forward

  • Biobusiness Briefs
  • Published:

From Nature Reviews Drug Discovery

View current issue Sign up to alerts

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Figure 1: Earliest priority year and approval year for patented new molecular entities approved in the United States between 1995 and 2013.

Acknowledgements

This research is funded by a grant (ES/K010999/1) from the UK Economic and Social Research Council (ERSC). The authors wish to thank Scott Hemphill and Duncan Matthews for their comments on earlier drafts.

Author information

Authors and Affiliations

  1. Department of Health Policy and Management, Mailman School of Public Health at Columbia University, 722 West 168th Street, 4th Floor, New York, 10032, New York, USA

    Bhaven N. Sampat

  2. Department of International Development, London School of Economics and Political Science, Houghton Street, London, WC2A 2AE, UK

    Kenneth C. Shadlen

Authors
  1. Bhaven N. Sampat
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Kenneth C. Shadlen
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Kenneth C. Shadlen.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Related links

PowerPoint slides

Supplementary information

Supplementary information S1 (table)

Priority and approval year of drugs approved 1995–2012 that are among the top 50 selling drugs in 2012 (PDF 96 kb)

Supplementary information S2 (box)

Constructing a list of all new molecular entity (NME) drug approvals between 1995 and 2013 (PDF 128 kb)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Sampat, B., Shadlen, K. Drug patenting in India: looking back and looking forward. Nat Rev Drug Discov 14, 519–520 (2015). https://doi.org/10.1038/nrd4681

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nrd4681

  • Springer Nature Limited

This article is cited by

Search

Navigation